True Private Wealth Advisors Gilead Sciences, Inc. Transaction History

True Private Wealth Advisors

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$73.27 - $83.09 $188,450 - $213,707	2,572 New	2,572 $208,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $154,553 - $221,885	2,480 New	2,480 $212,000
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $182,042 - $228,118	-3,143 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $908 - $1,030	-14 Reduced 0.44%	3,143 $228,000
Q3 2021 Nov 05, 2021	BUY	$67.69 - $73.03 $213,697 - $230,555	3,157 New	3,157 $220,000
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $2.13 Million - $2.44 Million	-35,581 Closed	0 $0
Q4 2020 Jan 11, 2021	SELL	$56.65 - $64.55 $108,711 - $123,871	-1,919 Reduced 5.12%	35,581 $2.07 Million
Q3 2020 Oct 09, 2020	BUY	$62.1 - $78.08 $352,603 - $443,338	5,678 Added 17.84%	37,500 $2.37 Million
Q2 2020 Jul 07, 2020	BUY	$72.34 - $84.0 $36,531 - $42,420	505 Added 1.61%	31,822 $2.45 Million
Q1 2020 Apr 20, 2020	BUY	$62.63 - $80.22 $1.94 Million - $2.48 Million	30,926 Added 7909.46%	31,317 $2.34 Million
Q4 2019 Jan 27, 2020	BUY	$61.62 - $67.78 $24,093 - $26,501	391 New	391 $25,000
Q3 2019 Oct 09, 2019	SELL	$62.51 - $69.0 $18,190 - $20,079	-291 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$61.87 - $69.38 $18,004 - $20,189	291 New	291 $19,000
Q4 2018 Jan 14, 2019	SELL	$60.54 - $79.0 $136,517 - $178,145	-2,255 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$71.28 - $78.92 $160,736 - $177,964	2,255 New	2,255 $0
Q1 2018 Apr 25, 2018	SELL	$72.84 - $88.8 $237,094 - $289,044	-3,255 Closed	0 $0
Q4 2017 Jan 19, 2018	BUY	$71.15 - $83.52 $231,593 - $271,857	3,255	3,255 $233,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.